The FDA has once again put off a decision on whether the controversial morning after pill known as "Plan B" can be sold over the counter.
The agency announced Friday it will spend the next two months hearing public comments on whether the pill can be sold over-the-counter for age 16 and older, by prescription only for younger girls.
Commissioner Lester Crawford said the agency wants to take a closer look at its own rules. Specifically, whether the FDA can designate over-the-counter status for any medicine, based on age alone.
To read the complete FDA statement on Plan B: Click Here